Long-Term Outcome After Liver Transplantation for Hepatocellular Carcinoma Following Yttrium-90 Radioembolization Bridging Treatment

BACKGROUND: Bridging treatments are employed in liver transplant waitlist patients with hepatocellular carcinoma (HCC) because of the risk of tumor progression during the waiting time. Radioembolization is mostly employed in the control of large or multifocal HCCs when other locoregional treatment m...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Transplant
Hlavní autoři: Radunz, Sonia, Treckmann, Jürgen, Baba, Hideo A., Best, Jan, Müller, Stefan, Theysohn, Jens M., Paul, Andreas, Benkö, Tamás
Médium: Artigo
Jazyk:Inglês
Vydáno: International Scientific Literature, Inc. 2017
Témata:
Original Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6248013/
https://ncbi.nlm.nih.gov/pubmed/28408731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.902595
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky